199 related articles for article (PubMed ID: 29699921)
1. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy with a passive beam: Organ doses in prostate cancer treatment.
Yonai S; Matsufuji N; Akahane K
Phys Med; 2018 Jul; 51():48-55. PubMed ID: 29699921
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo study of out-of-field exposure in carbon-ion radiotherapy: Organ doses in pediatric brain tumor treatment.
Matsumoto S; Yonai S; Bolch WE
Med Phys; 2019 Dec; 46(12):5824-5832. PubMed ID: 31603561
[TBL] [Abstract][Full Text] [Related]
3. Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation.
Yonai S; Matsufuji N; Namba M
Med Phys; 2012 Aug; 39(8):5028-39. PubMed ID: 22894428
[TBL] [Abstract][Full Text] [Related]
4. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
5. Measurement of neutron ambient dose equivalent in carbon-ion radiotherapy with an active scanned delivery system.
Yonai S; Furukawa T; Inaniwa T
Radiat Prot Dosimetry; 2014 Oct; 161(1-4):433-6. PubMed ID: 24126486
[TBL] [Abstract][Full Text] [Related]
6. Development of the DICOM-based Monte Carlo dose reconstruction system for a retrospective study on the secondary cancer risk in carbon ion radiotherapy.
Furuta T; Koba Y; Hashimoto S; Chang W; Yonai S; Matsumoto S; Ishikawa A; Sato T
Phys Med Biol; 2022 Jul; 67(14):. PubMed ID: 35781266
[No Abstract] [Full Text] [Related]
7. Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction in the secondary neutron dose.
Yonai S; Matsufuji N; Kanai T
Med Phys; 2009 Oct; 36(10):4830-9. PubMed ID: 19928113
[TBL] [Abstract][Full Text] [Related]
8. Measurement of absorbed dose, quality factor, and dose equivalent in water phantom outside of the irradiation field in passive carbon-ion and proton radiotherapies.
Yonai S; Kase Y; Matsufuji N; Kanai T; Nishio T; Namba M; Yamashita W
Med Phys; 2010 Aug; 37(8):4046-55. PubMed ID: 20879566
[TBL] [Abstract][Full Text] [Related]
9. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
Bednarz B; Hancox C; Xu XG
Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of potential irradiation geometries for carbon-ion beam grid therapy.
Tsubouchi T; Henry T; Ureba A; Valdman A; Bassler N; Siegbahn A
Med Phys; 2018 Mar; 45(3):1210-1221. PubMed ID: 29319842
[TBL] [Abstract][Full Text] [Related]
11. Testicular doses in image-guided radiotherapy of prostate cancer.
Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo assessment of beam deflection and depth dose equivalent variation of a carbon-ion beam in a perpendicular magnetic field.
Akbari M; Karimian A
Phys Med; 2019 May; 61():33-43. PubMed ID: 31151577
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
15. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.
Bednarz B; Athar B; Xu XG
Med Phys; 2010 May; 37(5):1987-94. PubMed ID: 20527532
[TBL] [Abstract][Full Text] [Related]
18. Monte carlo simulation study on the dose and dose-averaged linear energy transfer distributions in carbon ion radiotherapy.
Ishikawa A; Koba Y; Furuta T; Chang W; Yonai S; Matsumoto S; Hashimoto S; Hirai Y; Sato T
Radiol Phys Technol; 2024 Jun; 17(2):553-560. PubMed ID: 38570400
[TBL] [Abstract][Full Text] [Related]
19. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
20. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
